📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dose Prediction for Repurposing Nitazoxanide in SARS-CoV-2 Treatment or Chemoprophylaxis (2020)

First Author: Rajoli R

Attributed to: MICA: New combination therapy against MDR TB targeting the respiratory chain funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.22541/au.158938595.50403411

Publication URI: http://dx.doi.org/10.22541/au.158938595.50403411

Type: Preprint